UMA believes Europe—not Silicon Valley—is the best place to build the robots of tomorrow. LightOn's revenue prospects grow dim. France's defense and security are all about sovereignty when it comes to AI. Except when they are not. And an un-AI commercial goes viral for being, well, not AI.
A new French startup believes Europe—not Silicon Valley—is the best place to build the robots of tomorrow.
Between Dec 8 and Dec 12, French Tech startups raising money included Evertrust, Slash Intérim, GetMint, Corma, Monomeris Chemicals, Hocoia, Keria, and Onsen.
The insect protein company was finally marked for liquidation $625 million later. Hexa gets a house in SF. Clara Chappaz scores a digital government trifecta. Slash Intérim CEO Emma Capton reveals her strategy to reinvent temp work.
Emma Capron, Founder & CEO of Slash Intérim, felt the temp-work sector had been stuck in a time capsule. She decided to jailbreak it. Revenues doubled last year, and the company just raised €6M.
Special aiPulse edition: Gradium emerges from stealth with a €60M seed to make real-time voice the global AI interface. Yann LeCun exits Meta to chase world models, warning that Silicon Valley’s ChatGPT obsession is blinding it to the next revolution, and Paris may lead it.
The legendary AI scientist left Meta to build world models. He says Silicon Valley is too hypnotized by ChatGPT to see what's coming next.
The Paris startup, spun out of research lab Kyutai, just emerged from stealth with a $60M seed round to become the global foundation layer for real-time voice interactions.
Between Dec 1 and Dec 5, French Tech startups raising money included Gradium, Axoltis Pharma, Spark Cleantech, Bitstack, Innerskin, Ray studios, 2501.ai, ECAIR, Veragrow, Basalt, ReSoil, Kimialys, Minitap, ROB’OCC, Arrago, Annette, Néosylva, BiPER Therapeutics, and Vulgaroo.
Brevo’s €500M PE-led liquidity deal crowns it a unicorn and resets the French-tech cap table, arming the company for U.S. expansion, M&A, and AI acceleration. Plus: a new TechBio map spots 40 French startups fusing biology and deeptech.
A comprehensive mapping by France Biotech and France Deeptech identifies 40 companies operating at the intersection of biology and breakthrough technology, and argues that France could become a global leader in this emerging field.
Brevo’s €1bn valuation was driven by a PE-led growth buyout: General Atlantic and Oakley take 50%, Partech exits, and the cap table resets. It’s a landmark French-tech liquidity moment that gives Brevo powerful partners for U.S. expansion, bigger M&A, and AI-powered growth.
Mistral AI unloads Mistral 3. Gradium spins out of Kyutai to ride the Voice AI wave. UMA Robotics emerges out of stealth with a humanoid robotics "supergroup." HyprView Co-founder Victor Outters explains how the company is using photonics and AI to turn tumor light signatures into readable biology.
Thanks to developments in AI, photonics is stepping out of the lab and into the clinic. HyprView uses light to uncover the invisible biology inside tumors - information microscopes miss entirely - opening the door to faster, smarter, and far more predictive cancer diagnostics.
Between Nov 24 and Nov 28, French Tech startups raising VC included Zadient Technologies, AFYREN, Lexip (formerly Pixminds), Water Horizon, Damae Medical, VESTO, Alkion BioInnovations, Ventuno Biotech, Sim&Cure, AURA AERO, Komia, AberActives, Drive Innov, VoilaChef, AlgenScribe, and IvySpec.
Members of the Doctolib mafia have a new startup, La Fraise, that dentists and their patients can't refuse. We're looking over a new Future of Work fund called Clover. Revaia takes the ESG pulse. And Jolt is raising a €1B fund to make startup rhinoceroses a thing.
